Organizer: The Center for Professional Innovation & Education

Start: Monday, 16 October 2017 @ 09:00

End: Tuesday, 17 October 2017 @ 17:00

Timezone: Central European Time Zone

Sponsors: The Center for Professional Innovation & Education

Contact: info@cfpie.com

Venue: The Berlin Hilton

City: Berlin

Country: Germany

Target audience:
  • Pharmaceutical
  • Medical Device
  • Biotech
Description:

This two-day course is designed to provide individuals with a detailed understanding of the important regulatory guidelines involved in the development of a new product plan within the EU. The program will also cover effective strategies for correctly applying the current regulations to ensure that rejections are avoided.

The course will provide the attendee with a thorough knowledge of the following topics:
•How to develop a regulatory strategy
•How to deal with pricing and reimbursement issues in your development
•How to validate your regulatory strategy (scientific advice) and how to choose between centralized and national scientific advice
•When does your product qualify as an orphan medicinal product and what are the advantages if it does?
•How to deal with pediatric development plans
•What has to be considered for Advanced Therapy Medicinal Product and oncology medicinal products

Capacity: 20

Eligibility:
  • First come first served

Keywords: regulatory strategy, European Union Regulatory Issues , new product plan

European Union Regulatory Issues - New Product Development https://tess.elixir-europe.org/events/european-union-regulatory-issues-new-product-development This two-day course is designed to provide individuals with a detailed understanding of the important regulatory guidelines involved in the development of a new product plan within the EU. The program will also cover effective strategies for correctly applying the current regulations to ensure that rejections are avoided. The course will provide the attendee with a thorough knowledge of the following topics: •How to develop a regulatory strategy •How to deal with pricing and reimbursement issues in your development •How to validate your regulatory strategy (scientific advice) and how to choose between centralized and national scientific advice •When does your product qualify as an orphan medicinal product and what are the advantages if it does? •How to deal with pediatric development plans •What has to be considered for Advanced Therapy Medicinal Product and oncology medicinal products 2017-10-16 09:00:00 UTC 2017-10-17 17:00:00 UTC The Center for Professional Innovation & Education The Berlin Hilton, Berlin, Germany The Berlin Hilton Berlin Germany [] info@cfpie.com The Center for Professional Innovation & Education PharmaceuticalMedical DeviceBiotech 20 [] first_come_first_served regulatory strategyEuropean Union Regulatory Issues new product plan